Thеre can be no restraint of trade without a restraint. That truism decides this case, in which eight ophthalmologists contend that the American Academy of Ophthalmology violated the antitrust laws by attaching the label “experimental” to radial keratotomy, a surgical procedure for correcting nearsightedness.
*398 Nearsightedness (myopia) occurs when the cornea of the eye does not focus light on thе retina. A thick cornea bends light excessively, so that the focal point falls short of the vision receptors. Glasses and contact lenses correct the problem by introducing an offsetting distortion; the nеt effect of the series of lenses is a proper focal point. Radial keratotomy corrects the problem surgically. The ophthalmologist makes shallow incisions along radii of the cornea; as the cornea heals it becomes flatter, and vision improves.
Svyatoslav Fyodorov of the Soviet Union devised radial keratotomy in 1973. American physicians, including some of the plaintiffs, started performing the operation in 1978. Even the most promising medical developments often turn out to have drawbacks, whose nature and magnitude should be determined. Many who have undergone radial keratotomy reрort improvement in their eyesight (sometimes so much change that they become farsighted). What are the long-run consequences? Most persons’ visual acuity slowly changes with time. Does the eyesight of those who have had this operation change in different ways? Might the invasive procedure weaken the eye in a way that creates problems of a different kind? A surgical procedure used in Japan in the 1950s caused “corneal de-compensation” about ten years later, a serious condition leading to blindness (avoidable with corneal transplants). Radial ker-atotomy is different, but once burned twice shy.
In January 1979 the National Advisory Eye Council, the principal advisory body to the National Eye Institute (part of the National Institutes of Health) called refractive keratoplasty (a group of surgical procеdures that includes radial keratotomy) “experimental”. In 1980 it applied this term to radial keratotomy specifically, calling on the profession to use restraint until more research could be done. As thе federal government does not regulate surgical procedures, this was all a federal body could do. In June 1980 the board of directors of the American Academy of Ophthalmology —the largest assoсiation of ophthalmologists, with more than 9,400 members — endorsed the Eye Council’s position. It issued a press release urging “patients, ophthalmologists and hospitals to approach [radial keratotоmy] with caution until additional research is completed.”
This suit under § 1 of the Sherman Act, 15 U.S.C. § 1, contends that the press release issued in 1980 was the upshot of a conspiracy among the Academy’s members in restraint of trаde. After a month of trial, the jury disagreed. The plaintiffs press objections to the jury instructions, including the district judge’s puzzling refusal to define a product market even though the first question in any rule of reason case is markеt power.
Ball Memorial Hospital, Inc. v. Mutual Hospital Insurance, Inc.,
Plaintiffs concede that the Academy did not attempt to coordinate activities with these groups, aсtors independent of the Academy. Cf.
Business Electronics Corp. v. Sharp Electronics Corp.,
Antitrust law is about consumers’ welfare and the efficient organization of production. It condemns reductions in output that drive up prices as consumers bid for the remaining suрply.
NCAA v. University of Oklahoma,
Ophthаlmologists are each others’ rivals for custom. They offer competing procedures to cope with myopia — some surgical, some optical (glasses plus contact lenses of many kinds: hard, soft, extended wear). Plaintiffs say that the Academy is in the grip of professors and practitioners who favor conservative treatment, forever calling for more research (the better to justify the acаdemics’ requests for grants); plaintiffs portray themselves as the progressives, disdaining the Academy’s fuddy-dud-dies in order to put the latest knowledge to work. Warfare among suppliers and their different products
is
comрetition. Antitrust law does not compel your competitor to praise your product or sponsor your work. To require cooperation or friendliness among rivals is to undercut the intellectual foundаtions of antitrust law.
Indiana Grocery,
Consolidated Metal Products, Inc. v. American Petroleum Institute,
Plaintiffs’ “smoking guns” show how far this case strayed from the point of antitrust law. Plaintiffs observe that the Academy never before had callеd a surgical procedure “exnerimentakk — that it acted .on the recommendation of the Eye Banks Committee, which they~ view — as'unfit to render advice about the topic (after 1982 the Academy gave thе subject to a different committee); that the Academy’s president in 1980 admitted that he wanted to stop the “proliferation” of radial keratoto-my (one would expect no less if he thought the procedure should be treated as “experimental”). Then there isJfoe crowning insult: in 1981 the Academy's president and idiotic” for tldemandinsr that I answer a series of eight ornine questions which he had seen fit to puttome", “despite [plaintiffs say] having had ... DrT'Schachar’s chief of surgerv-at the University of Chicago tell him that Dr. Schachar was among the very brightest students heJiad ever taught.” We may_assume that,professors at the University of 'Chicago^ireJnfallible judges of talent and that bright ophthalmologists have flawless judgment; what this bickering has to do with the Sherman Act is a mystery. Animosity, even if rephrased as “anticompetitive intent”, is not illegal without anticompetitive effects.
Moore,
Plaintiffs’ fundamental position, stated in its reply brief, is that: “Issuing such a statement [calling rаdial keratotomy “experimental”] carried with it an obligation to the public, ophthalmologists, and third party payors to have studied the procedure and reached a considered opinion.” Putting tо one side the conundrum that once you have “studied” something it is no longer “experimental” — that the declaration of “experimental” status logically precedes the gathering of information — we do not perceive what this has to do with antitrust. See
Indiana Grocery,
AFFIRMED.
